You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
POSTER: CASE STUDY<br />
Poster: Case Study<br />
P 354<br />
TOTAL TREATMENT APPROACH OF A DIABETIC PATIENT WITH TROPHIC<br />
ULCERS – A CASE STUDY<br />
A.N. Begma 1<br />
1 Federal State Budget Institution, State Scientific Center «Laser Medicine» Federal<br />
Medical and Biolo (Moscow, Russia).<br />
Introduction: A total treatment approach may be effective in complex cases. The aim of<br />
this case study was to provide an integrated approach evaluating the efficacy of the<br />
treatment regime per wound stage.<br />
Methods: Case ascertainment was used. The 68-year-old female patient has had<br />
diabetes type 1 for 18 years and a history of cerebral vascular accident. Since 2010 she<br />
had an ulcer on her anterolateral right leg which had increased from 9 cm 2 to 50 cm 2<br />
within six months. She was admitted to the hospital with an even larger ulcer of 138 cm 2 .<br />
Her venous circulation and arterial blood supply was normal. The 0.3 mm deep ulcer<br />
contained 32% black necrosis and 68% slough. Wound edges and peri-ulcer skin looked<br />
healthy. Patient reported ulcer pain was VAS 7.4.<br />
A *hydrogel was applied on the black necrosis and an **alginate covered the rest of the<br />
ulcer. A ***film was used as a secondary dressing. Dressing changes were every two<br />
days.<br />
Results: After 9 days slough had reduced to 28% of the ulcer surface. Patient reported<br />
pain was VAS 3.2. The dressing regime was changed to a ****bio-cellulose dressing +<br />
PHMB covered with a film dressing with twice weekly dressing changes, until complete<br />
wound bed preparation, after three weeks. After skin grafting for protection a<br />
*****hydrocolloid was applied for 7 days.<br />
Conclusion: The dressing regime was shown to be effective and allowed for<br />
comfortable ulcer closure.<br />
*Suprasorb ® G<br />
**Suprasorb ® A<br />
***Suprasorb ® F<br />
****Suprasorb ® X + PHMB<br />
*****Suprasorb ® H, Lohmann & Rauscher<br />
P 355<br />
WHEN OEDEMA REDUCTION IS NOT ENOUGH<br />
– CASE STUDY OF A LYMPHEDEMA PATIENT<br />
Poster: Case Study<br />
Ria van Dam 1 , Alice van den Wijngaard 2<br />
1 Boerhaave Foundation for Nursing homes, location: St. Jacob (Haarlem, Netherlands);<br />
2 Lohmann & Rauscher (Almere, Netherlands).<br />
Aim: Management of patients with lymphedema is well established in the Netherlands.<br />
However it is not evident that outcomes are successful. Aim of the case study was to<br />
identify risk factors and to correct flaws in the patients’ treatment regime, leading to<br />
successful outcome.<br />
Method: Case ascertainment was used in the 80 year-old non concordant female patient<br />
with combined venous lymphatic ulceration. Mainstay of lymphedema treatment is skin<br />
care, exercise and compression with rigid bandages. To optimise concordance it is<br />
important to analyse the individual patient issues and to adapt the treatment regime<br />
accordingly. The ulcers on both her forefoot and lower legs had recurred due to friction of<br />
ill-fitting shoes and socks. The other ulcers on her lower legs had closed. The complete<br />
regime was revised, using a less bulky *two component compression system, a<br />
**collagen dressing and specialist lymphedema footwear.<br />
Results: Skin lesions and ulcers were closed within 6 weeks and the reduction of edema<br />
was 12 cm (measured at the calf) per week for the first 3 weeks. After 4 months of<br />
treatment the patient was fitted ready to wear compression stockings for maintenance<br />
therapy, continuing with skin care and specialist footwear.<br />
Conclusion: To prevent recurrence, identification of risk factors, optimizing concordance<br />
with maintenance therapy is key. The less-bulky compression system allowed for better<br />
fitting of footwear. Ulcer healing and reduction of edema was achieved in a patientfriendly<br />
and effective manner within 4 months of treatment.<br />
*Rosidal TCS<br />
**Suprasorb ® C; Lohmann & Rauscher<br />
<strong>EWMA</strong> <strong>2013</strong><br />
COPENHAGEN<br />
15-17 May · <strong>2013</strong><br />
Danish Wound<br />
Healing Society<br />
207